HomeNLSPW • NASDAQ
add
NLS Pharmaceutics AG
Previous close
$0.019
Day range
$0.015 - $0.021
Year range
$0.00090 - $0.070
Market cap
44.45M USD
Avg Volume
47.59K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (ILS) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.45M | 138.72% |
Net income | -1.11M | -9.08% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.40M | -134.89% |
Effective tax rate | 0.45% | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.07M | 455.83% |
Total assets | 4.34M | 263.45% |
Total liabilities | 1.46M | -86.09% |
Total equity | 2.88M | — |
Shares outstanding | 4.15M | — |
Price to book | -0.00 | — |
Return on assets | -394.30% | — |
Return on capital | 14.50% | — |
Cash Flow
Net change in cash
| (ILS) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.11M | -9.08% |
Cash from operations | -1.04M | -35.50% |
Cash from investing | — | — |
Cash from financing | 500.00K | -15.65% |
Net change in cash | 703.49K | 507.91% |
Free cash flow | -645.88K | -78.60% |
About
Founded
2008
Headquarters
Website
Employees
1
